Owner Amgen Inc.

Inventors Fotsch, Christopher H.; Rishton, Gilbert M.; Harrington, Paul E.; Miller, Philip; Ghiron, Chiara; Coulter, Thomas S.; Semin, David J.; Kelly, Michael G.; St. Jean Jr., David J.

Agent Shelston IP

Pub. Number AU-A-2008311974

PCT Pub. Number WO2009/051718

Priority 60/998,933 15.10.07 US

Filing date 15 October 2008

Wipo publication date 23 April 2009

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 207/335 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/48 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/16 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/22 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 277/28 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings